The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II/III study of perioperative nivolumab and ipilimumab in patients (pts) with locoregional esophageal (E) and gastroesophageal junction (GEJ) adenocarcinoma: Results of a safety run-in—A trial of the ECOG-ACRIN Cancer Research Group (EA2174).
 
Jennifer Rachel Eads
Employment - Bristol-Myers Squibb (I)
Honoraria - Pfizer
Consulting or Advisory Role - Advanced Accelerator Applications; Ipsen; lexicon
Research Funding - Incyte; MedImmune (Inst); Tarveda Therapeutics (Inst); Xencor (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb (I)
 
Michelle Weitz
No Relationships to Disclose
 
Paul J. Catalano
Research Funding - Celgene (Inst)
 
Michael K. Gibson
Consulting or Advisory Role - Abbvie; Flagship Biosciences; Soligenix
Speakers' Bureau - Bristol-Myers Squibb
 
Lakshmi Rajdev
No Relationships to Disclose
 
Onkar Khullar
No Relationships to Disclose
 
Steven H. Lin
Employment - MD Anderson Cancer Center
Honoraria - AstraZeneca/MedImmune; BeyondSpring Pharmaceuticals
Speakers' Bureau - AstraZeneca
Research Funding - BeyondSpring Pharmaceuticals; Hitachi Chemical; Nektar
Travel, Accommodations, Expenses - Elekta; STCube Pharmaceuticals Inc.
 
Constantine Gatsonis
No Relationships to Disclose
 
Ignacio Ivan Wistuba
Consulting or Advisory Role - AstraZeneca/MedImmune; Asuragen; Bayer; Bristol-Myers Squibb; Flame Biosciences; Flame Biosciences; Genentech/Roche; GlaxoSmithKline; Guardant Health; HTG Molecular Diagnostics; Merck; MSD Oncology; OncoCyte; Pfizer
Speakers' Bureau - AstraZeneca; Merck; MSD Oncology; Pfizer; Roche
Research Funding - 4D Molecular Therapeutics (Inst); Adaptimmune (Inst); Adaptive Biotechnologies (Inst); Akoya Biosciences (Inst); Amgen (Inst); Bayer (Inst); EMD Serono (Inst); Genentech (Inst); Guardant Health (Inst); HTG Molecular Diagnostics (Inst); Iovance Biotherapeutics (Inst); Johnson & Johnson (Inst); Karus Therapeutics (Inst); MedImmune (Inst); Merck (Inst); Novartis (Inst); OncoPlex Diagnostics (Inst); Pfizer (Inst); Silicon Biosytems (Inst); Takeda (Inst)
 
Aravind Sanjeevaiah
Consulting or Advisory Role - Legend Biotech; Legend Biotech
Travel, Accommodations, Expenses - NanoCarrier
 
Al Bowen Benson
Consulting or Advisory Role - American Cancer Society; Array BioPharma; BioNest; Bristol-Myers Squibb; Cancer Expert Now; Decision Resources; Harborside Press; Health Advances; i3 Health; Imedex; Lynx Group; Merck Sharp & Dohme; Merck Sharp & Dohme; Precisca; PrECOG; Research to Practice; Shanghai International Colorectal Cancer Symposium; Springer; The Dedham Group; Total Health Conferencing
Research Funding - Advanced Accelerator Applications (Inst); American College of Radiology (Inst); Amgen (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); ECOG-ACRIN (Inst); Elevar Therapeutics (Inst); Infinity Pharmaceuticals (Inst); MedImmune (Inst); Merck Sharp & Dohme (Inst); PrECOG (Inst); Rafael Pharmaceuticals (Inst); st pharm (Inst); SynCoreBio (Inst); Taiho Pharmaceutical (Inst); Tyme Inc (Inst); Xencor (Inst)
Travel, Accommodations, Expenses - Array BioPharma; Association of Community Cancer Centers (ACCC); Bristol-Myers Squibb; CancerCare; Lynx Group; Merck Sharp & Dohme; MJH Healthcare Holdings, LLC; NCCN; North American Neuroendocrine Tumor Society; NPAF/PAF
 
Nathan Bahary
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Celgene; Exelixis; Thermo Fisher Scientific
 
Kristen Renee Spencer
Consulting or Advisory Role - QED Therapeutics
 
Nabil F. Saba
Honoraria - BioNTech; CUE Biopharma; Merck
Consulting or Advisory Role - GlaxoSmithKline
Research Funding - Bristol-Myers Squibb; Exelixis
Travel, Accommodations, Expenses - Blueprint Medicines; GlaxoSmithKline; Merck; Pfizer
 
Stanley R. Hamilton
Stock and Other Ownership Interests - Johns Hopkins University School of Medicine
Consulting or Advisory Role - Bristol-Myers Squibb; Cell Medica/Kuur Therapeutics; Guardant Health; HalioDx; Loxo; Merck; Thermo Fisher Scientific
 
Charles A. Staley
No Relationships to Disclose
 
Bapsi Chakravarthy
No Relationships to Disclose
 
George A. Fisher
Stock and Other Ownership Interests - Seagen (I)
Honoraria - Advanced Accelerator Applications; Ipsen
Consulting or Advisory Role - Ipsen; Merck; Taiho Pharmaceutical
Research Funding - Aduro Biotech (Inst); Forty seven (Inst); Genentech/Roche (Inst); Merck (Inst); Newlink Genetics (Inst)
Travel, Accommodations, Expenses - Merck; Roche/Genentech
Other Relationship - AstraZeneca; CytomX Therapeutics; Hutchison MediPharma; Silenseed; Taiho Pharmaceutical; Terumo Clinical Supply
 
Terence Z. Wong
No Relationships to Disclose
 
Peter J. O'Dwyer
Consulting or Advisory Role - Array BioPharma; Genentech
Research Funding - Amgen (Inst); Array BioPharma (Inst); BBI Healthcare (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Five Prime Therapeutics (Inst); Forty Seven (Inst); Genentech (Inst); GlaxoSmithKline (Inst); H3 Biomedicine (Inst); Lilly/ImClone (Inst); Minneamrita Therapeutics (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Pharmacyclics (Inst); Syndax (Inst); Syndax (Inst); Syndax (Inst); syndax (Inst); Syndax (Inst); Taiho Pharmaceutical (Inst)
Expert Testimony - Lilly